These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 34378540)
41. Design, synthesis, and biological evaluation of indazole derivatives as selective and potent FGFR4 inhibitors for the treatment of FGF19-driven hepatocellular cancer. Chen X; Liu Y; Zhang L; Chen D; Dong Z; Zhao C; Liu Z; Xia Q; Wu J; Chen Y; Zheng X; Cai Y Eur J Med Chem; 2021 Mar; 214():113219. PubMed ID: 33618175 [TBL] [Abstract][Full Text] [Related]
42. Design, synthesis and bioactivity evaluation of favorable evodiamine derivative scaffold for developing cancer therapy. Liang Z; Wang Y; Zhang H; Deng J; Lei F; Li J; Shi T; Wang S; Li R; Wang Z Eur J Med Chem; 2022 Sep; 239():114530. PubMed ID: 35728506 [TBL] [Abstract][Full Text] [Related]
43. Synthesis, in vitro and in vivo evaluation of novel substituted N-(4-(2-(4-benzylpiperazin-1-yl)ethoxy)phenyl)-N-methyl-quinazolin-4-amines as potent antitumor agents. Cao D; Wang X; Lei L; Ma L; Wang F; Wang C; Tang M; Xiang W; Wang T; Li H; Chen L Bioorg Med Chem Lett; 2016 Apr; 26(8):1931-5. PubMed ID: 26979159 [TBL] [Abstract][Full Text] [Related]
44. A branched small molecule-drug conjugate nanomedicine strategy for the targeted HCC chemotherapy. Li SS; Zhang CM; Wu JD; Liu C; Liu ZP Eur J Med Chem; 2022 Jan; 228():114037. PubMed ID: 34883290 [TBL] [Abstract][Full Text] [Related]
46. Inhibition of mitochondrial respiration overcomes hepatocellular carcinoma chemoresistance. Sun Y; Xu H; Chen X; Li X; Luo B Biochem Biophys Res Commun; 2019 Jan; 508(2):626-632. PubMed ID: 30522865 [TBL] [Abstract][Full Text] [Related]
47. 2-Styryl-4-aminoquinazoline derivatives as potent DNA-cleavage, p53-activation and in vivo effective anticancer agents. Wei XW; Yuan JM; Huang WY; Chen NY; Li XJ; Pan CX; Mo DL; Su GF Eur J Med Chem; 2020 Jan; 186():111851. PubMed ID: 31761381 [TBL] [Abstract][Full Text] [Related]
48. Scaffold Hopping of Natural Product Evodiamine: Discovery of a Novel Antitumor Scaffold with Excellent Potency against Colon Cancer. Wang L; Fang K; Cheng J; Li Y; Huang Y; Chen S; Dong G; Wu S; Sheng C J Med Chem; 2020 Jan; 63(2):696-713. PubMed ID: 31880942 [TBL] [Abstract][Full Text] [Related]
49. Shikonin, a Chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: A potential new treatment for hepatocellular carcinoma. Gong K; Li W Free Radic Biol Med; 2011 Dec; 51(12):2259-71. PubMed ID: 22011623 [TBL] [Abstract][Full Text] [Related]
50. 5H-benzo[h]thiazolo[2,3-b]quinazolines ameliorate NDEA-induced hepatocellular carcinogenesis in rats through IL-6 downregulation along with oxidative and metabolic stress reduction. Keshari AK; Singh AK; Kumar U; Raj V; Rai A; Kumar P; Kumar D; Maity B; Nath S; Prakash A; Saha S Drug Des Devel Ther; 2017; 11():2981-2995. PubMed ID: 29075102 [TBL] [Abstract][Full Text] [Related]
51. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway. Li T; Dong ZR; Guo ZY; Wang CH; Zhi XT; Zhou JW; Li DK; Chen ZT; Chen ZQ; Hu SY Liver Int; 2015 Apr; 35(4):1416-29. PubMed ID: 25066210 [TBL] [Abstract][Full Text] [Related]
52. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells. Yang J; Cai X; Lu W; Hu C; Xu X; Yu Q; Cao P Cancer Lett; 2013 Jan; 328(2):243-51. PubMed ID: 23032719 [TBL] [Abstract][Full Text] [Related]
53. Design, synthesis, molecular modelling, and biological evaluation of novel substituted pyrimidine derivatives as potential anticancer agents for hepatocellular carcinoma. Ahmed NM; Youns M; Soltan MK; Said AM J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1110-1120. PubMed ID: 31117890 [TBL] [Abstract][Full Text] [Related]
54. Development of a DNA Aptamer against Multidrug-Resistant Hepatocellular Carcinoma for Zhang L; Zhou L; Zhang H; Zhang Y; Li L; Xie T; Chen Y; Li X; Ling N; Dai J; Sun X; Liu J; Zhao J; Peng T; Ye M ACS Appl Mater Interfaces; 2021 Nov; 13(46):54656-54664. PubMed ID: 34779207 [TBL] [Abstract][Full Text] [Related]
55. SH-7, a new synthesized shikonin derivative, exerting its potent antitumor activities as a topoisomerase inhibitor. Yang F; Chen Y; Duan W; Zhang C; Zhu H; Ding J Int J Cancer; 2006 Sep; 119(5):1184-93. PubMed ID: 16570288 [TBL] [Abstract][Full Text] [Related]
56. New brefeldin A-cinnamic acid ester derivatives as potential antitumor agents: Design, synthesis and biological evaluation. Jiang YY; Wu S; Wu YW; Gao Y; Chong D; Sun C; Wei MY; Gu YC; Shao CL; Gu Y Eur J Med Chem; 2022 Oct; 240():114598. PubMed ID: 35849940 [TBL] [Abstract][Full Text] [Related]
57. The anti-hepatocellular carcinoma cell activity by a novel mTOR kinase inhibitor CZ415. Zhang W; Chen B; Zhang Y; Li K; Hao K; Jiang L; Wang Y; Mou X; Xu X; Wang Z Biochem Biophys Res Commun; 2017 Jun; 487(3):494-499. PubMed ID: 28366631 [TBL] [Abstract][Full Text] [Related]
58. Treatment with a New Barbituric Acid Derivative Exerts Antiproliferative and Antimigratory Effects against Sorafenib Resistance in Hepatocellular Carcinoma. Liao YJ; Hsu SM; Chien CY; Wang YH; Hsu MH; Suk FM Molecules; 2020 Jun; 25(12):. PubMed ID: 32575795 [TBL] [Abstract][Full Text] [Related]
59. ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling. Ding J; Wen W; Xiang D; Yin P; Liu Y; Liu C; He G; Cheng Z; Yin J; Sheng C; Zhang W; Nan F; Ye W; Zhang X; Wang H Oncotarget; 2015 May; 6(13):11627-39. PubMed ID: 25890498 [TBL] [Abstract][Full Text] [Related]
60. Discovery of potent and novel dual NAMPT/BRD4 inhibitors for efficient treatment of hepatocellular carcinoma. Yin C; Jia S; Yang X; Wu L Eur J Med Chem; 2024 May; 271():116444. PubMed ID: 38691889 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]